Patent Pool to Fight HIV/Aids

Table of Contents

• Short Infos
• News
• Links
• Movies
• Archives Documents
  

Short Infos

News

• Medicines Patent Pool Signs Licence Agreement with Gilead to Increase Access to HIV/AIDS Medicines
  • Press release from the July 11, 2011
  • PDF, English
  • The Medicines Patent Pool and UNITAID today announce the first agreement between the Medicines Patent Pool and a pharmaceutical company - Gilead Sciences - to improve access to HIV and Hepatitis B treatment in developing countries. "This agreement is an improvement over what other big pharma companies are doing to ensure access to their patented AIDS medicines in developing countries,” said Michelle Childs, Policy and Advocacy Director at MSF’s Campaign for Access to Essential Medicines. “But some caution is needed because in several key areas, Gilead is not going beyond the status quo. More needs to be done to fulfil the vision of the Patent Pool to provide a solution to all people living with HIV, so this licence should not become the template for future agreements.” 
  • The Medicines Patent Pool/Gilead Licences: Questions and Answers
    • July 2011
    • PDF, English

Links

• Stop Aids Campaign: Support the Push for Life-Saving HIV Treatment!

• The Medicines Patent Pool at UNITAID

Movies

• "Push for the Pool" Campaign Video on Youtube
  • Dezember 2008
  • A movie by students of the "Stop Aids Campaign"

Archives Documents

• The Medicines Patent Pool – Stimulating Innovation, Improving Access
  • January 2011
  • PDF, English
  • The Medicines Patent Pool is working to bring down the prices of HIV drugs and encourage the development of desperately needed new formulations, such as medicines for children. The Pool does this through voluntary licensing of critical intellectual property - making patents work for public health, while giving pharmaceutical innovators compensation for their work.
  • by UNITAID

• Cipla Ltd. endorses Patent Pool, defends 3d and supports Canadian Bill
  • August 2009
  • PDF, English
  • An important statement from Dr Hamied, the only man who can turn a statement to shareholders into an access campaign speech. This is very important for the UNITAID pool as previously he was not certain; but he makes the important point that this needs to be linked to other safeguards under threat such as 3d  and the need to make licensing easier and so supports the present Canadian Bill to amend August 30th. This is an important manifesto for ensuring access in a post TRIPS world.
  • Address by Dr. Y.K. Hamied, Chairman and Managing Director of Cipla Ltd., at the Seventy-Third Annual General Meeting of Cipla Ltd.

• International Development Under-Secretary of State, Mike Foster, backs UNITAID Patent Pool and urges pharma companies to join
  • July 2009
  • from our News section, English
  • Fantastic news, Mike Foster, International Development Parliamentary Under-Secretary of State for United Kingdom, is backing the UNITAID HIV medicines patent pool and urging pharma companies to join.

• The Medicines Patent Pool Initiative by UNITAID
  
  • March 2009
  • PDF, English
  • UNITAID is working to establish an international system boost the availability of new and more patient-friendly medicines for people in developing countries. Through a collective management structure for medicines patents, known as a patent pool, UNITAID seeks to improve access to patents and foster the development and production of life-saving, more affordable, and more suitable medicines. Although such a ‘pool’ structure has shown its worth in many areas – agriculture and information technology, for example - the UNITAID initiative will lead to the first patentpool for medicines.
  • also check the Medicines Patent Pool: Questions & Answers

• The Guardian: Head of GlaxoSmithKline pledges cheap medicine for world's poor
  • 13 Februar 2009
  • External link, English, to the original article on The Guardian
    
    
  • The Guardian: Letter in response to GlaxoSmithKline's Patent Pool Proposal
    • 25. February 2009
    • External link, English, to the web site of of Médecins Sans Frontières' Campaign for Access to Essential Medicines
    • From the text: "This prescription for change needs to go much further. Drug giants need to back Unitaid's patent pool rather than dish out discounts."
    • by Dr Tido von Schoen-Angerer is director of Médecins Sans Frontières' Campaign for Access to Essential Medicines
  • UNITAID Statement on GSK Patent Pool for Neglected Diseases
    • February 2009
    • Word document, English
    • UNITAID welcomes GlaxoSmithKline’s (GSK’s) announcement last week that it will tackle neglected diseases in least developed countries and place its patents for the necessary medicines into a pool.